Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00199420 · ClinicalTrials.gov registry record · Phase 3
A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa
A Phase 3 study, sponsored by Kyowa Kirin.
- Completed
- Registry status
- Phase 3
- Development phase
- 580
- Enrollment target
NCT00199420 is a Phase 3 study that has completed, run by Kyowa Kirin. The registered enrollment target is 580 participants.
The verdict
NCT00199420, a Phase 3 study, has completed, sponsored by Kyowa Kirin.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 580 participants
- Enrollment target
Study Summary
To establish the efficacy of 10, 20 and 40 mg/d dose of istradefylline for reducing the percentage of OFF time in patients with advanced Parkinson's disease (PD) treated with levodopa.
Interventions
- DRUG Istradefylline (KW-6002)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 580 participants |
| Start Date | 2004-07 |
| Est. Completion | 2005-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00199420
The ClinicalTrials.gov registry entry for NCT00199420 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 580 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kyowa Kirin, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Istradefylline (KW-6002) is the first listed.
NCT00199420 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00199420 about?
NCT00199420 is a clinical study titled "A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa". To establish the efficacy of 10, 20 and 40 mg/d dose of istradefylline for reducing the percentage of OFF time in patients with advanced Parkinson's disease (PD) treated with levodopa.
What is the current status of trial NCT00199420?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 580 participants. The study started on 2004-07. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00199420?
The interventions under investigation include: Istradefylline (KW-6002) (DRUG).
Who is sponsoring clinical trial NCT00199420?
This trial is sponsored by Kyowa Kirin, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.